Financing
Share Buybacks
Vertex Pharmaceuticals Share Buybacks increased by 162.4% to $336.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 20.9%, from $426.10M to $336.90M. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows an upward trend with a 9.1% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2016
Last reportedQ1 2026May 5, 2026
How to read this metric
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
Detailed definition
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Peer comparison
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
Metric ID:
share_repurchasesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $632.30M | $368.20M | $0.00 | $0.00 | $0.00 | $0.00 | $132.80M | $28.30M | $117.00M | $149.50M | $131.20M | $320.30M | $307.70M | $417.90M | $426.10M | $391.80M | $1.07B | $128.40M | $336.90M |
| QoQ Change | — | — | -41.8% | -100.0% | — | — | — | — | -78.7% | +313.4% | +27.8% | -12.2% | +144.1% | -3.9% | +35.8% | +2.0% | -8.0% | +173.4% | -88.0% | +162.4% |
| YoY Change | — | — | — | — | — | -100.0% | -100.0% | — | — | — | — | -1.2% | >999% | +163.0% | +179.5% | +224.8% | +22.3% | +248.1% | -69.3% | -20.9% |
Range$0.00 – $1.07B
Avg YoY Growth+143.5%
Median YoY Growth+22.3%
Share Buybacks at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's share buybacks?
- Vertex Pharmaceuticals (VRTX) reported share buybacks of $336.90M in Q1 2026.
- How has Vertex Pharmaceuticals's share buybacks changed year-over-year?
- Vertex Pharmaceuticals's share buybacks decreased by 20.9% year-over-year, from $426.10M to $336.90M.
- What is the long-term trend for Vertex Pharmaceuticals's share buybacks?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's share buybacks has grown at a 9.1% compound annual growth rate (CAGR), from $1.43B to $2.02B.
- What does share buybacks mean?
- Cash spent by the company to buy back its own stock.